Trexquant Investment’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Trexquant Investment’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,504	Closed	-$511K	–	1975
2022 Q2	$511K	Buy	+3,504	New	+$448K	0.02%	815
2021 Q3	–	Sell	-7,418	Closed	-$720K	–	1643
2021 Q2	$720K	Buy	+7,418	New	+$602K	0.06%	385
2021 Q1	–	Sell	-11,891	Closed	-$1.02M	–	1641
2020 Q4	$1.02M	Buy	+11,891	New	+$1.01M	0.11%	253
2019 Q1	–	Sell	-6,276	Closed	-$232K	–	1495
2018 Q4	$232K	Buy	+6,276	New	+$226K	0.01%	866
2018 Q1	–	Sell	-12,836	Closed	-$346K	–	1591
2017 Q4	$346K	Buy	+12,836	New	+$353K	0.04%	679

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Trexquant Investment's BHVN Position: Q3 2022 in Review

Trexquant Investment sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 3,504 shares — an estimated $511K sold.

Trexquant Investment first reported a position in BHVN in Q4 2017 and held it in 5 quarters. The position peaked at $1.02M in Q4 2020. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Trexquant Investment reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
Trexquant Investment sold 3,504 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $511K.
Trexquant Investment first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 5 quarters.
Trexquant Investment's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.02M in Q4 2020.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.